ETFs Holding RDUS »    RDUS Historical Stock Prices »
RDUS News Video: Fri, Dec 8, 2017, 1:46 PM — Friday's ETF Movers: IBB, REM

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Radius Health is a biopharmaceutical company focused on developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. Co.'s commercial product, TYMLOSTM (abaloparatide) injection, is for the treatment of postmenopausal women with osteoporosis. Co. is also developing its investigational product candidate, elacestrant (RAD1901), a selective estrogen receptor degrader for use in the treatment of hormone-receptor positive breast cancer. Co. is developing its internally discovered investigational product candidate, RAD140, a non-steroidal selective androgen receptor modulator for use in the treatment of hormone-receptor positive breast cancer. Self directed investors in Radius Health Inc will be interested in keeping up with all Radius Health Inc news they can find, both RDUS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on RDUS. At RediNews, we simplify this task by presenting both RDUS news releases originating from Radius Health Inc itself, and RDUS news from a variety of media outlets. Visitors can browse this news online and through our RDUS RSS news feed.


RDUS News — Articles, Videos, & Press Releases

Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues
Thursday, May 9, 2019, 1:30 PM — Zacks
Noteworthy Friday Option Activity: CBLK, RDUS, ESNT
Friday, May 3, 2019, 3:20 PM — Stock Options Channel
Analysts Anticipate XBI Will Reach $129
Thursday, May 2, 2019, 8:23 AM — ETF Channel
Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales
Tuesday, April 16, 2019, 4:54 PM — Zacks
Why Is Radius Health (RDUS) Up 5.2% Since Last Earnings Report?
Saturday, March 30, 2019, 7:30 AM — Zacks
Radius Health Breaks Above 200-Day Moving Average - Bullish for RDUS
Friday, March 29, 2019, 4:46 PM — Market News Video
Analysts Expect 15% Gains Ahead For FYX
Wednesday, March 27, 2019, 7:47 AM — ETF Channel
Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales
Friday, March 1, 2019, 1:18 PM — Zacks
First Week of RDUS October 18th Options Trading
Friday, March 1, 2019, 10:33 AM — Stock Options Channel
Analysts Expect FTXH To Hit $27
Thursday, January 17, 2019, 8:12 AM — ETF Channel
Noteworthy Friday Option Activity: RDUS, GBT, MTW
Friday, January 11, 2019, 3:19 PM — Stock Options Channel
Interesting RDUS Put And Call Options For February 15th
Friday, January 4, 2019, 10:53 AM — Stock Options Channel
How The Pieces Add Up: IEIH Headed For $31
Wednesday, December 12, 2018, 8:12 AM — ETF Channel
First Week of July 2019 Options Trading For Radius Health (RDUS)
Wednesday, November 21, 2018, 11:24 AM — Stock Options Channel
Look Under The Hood: PXSG Has 31% Upside
Friday, November 9, 2018, 7:24 AM — ETF Channel
First Week of RDUS December 21st Options Trading
Thursday, October 25, 2018, 11:04 AM — Stock Options Channel
The Implied Analyst 12-Month Target For IBB
Friday, October 5, 2018, 7:47 AM — ETF Channel
IEIH's Holdings Could Mean 13% Gain Potential
Tuesday, September 4, 2018, 8:51 AM — ETF Channel
Relative Strength Alert For Radius Health
Friday, August 24, 2018, 4:16 PM — Dividend Channel
First Week of RDUS April 2019 Options Trading
Tuesday, August 21, 2018, 11:14 AM — Stock Options Channel
Analysts Expect IYH Will Reach $209
Thursday, August 2, 2018, 9:13 AM — ETF Channel
Radius Health is Now Oversold (RDUS)
Friday, July 27, 2018, 1:47 PM — Dividend Channel
Analysts See 11% Upside For IYY
Monday, July 2, 2018, 9:50 AM — ETF Channel
First Week of August 17th Options Trading For Radius Health (RDUS)
Monday, June 25, 2018, 10:49 AM — Stock Options Channel
Surprising Analyst 12-Month Target For IYY
Friday, June 1, 2018, 7:36 AM — ETF Channel
5 Howard Marks Holdings Attracting Short Sellers
Friday, May 25, 2018, 1:41 PM — Dividend Channel
Radius Health Enters Oversold Territory (RDUS)
Monday, May 21, 2018, 4:21 PM — Dividend Channel
RDUS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites you to integrate our free RSS news feeds. While web portal content experience like building out an investor relations web site is a major plus when working with our RSS feeds, you don't need stock quote feed experience to begin working with something as simple as RSS — which stands for Really Simple Syndication. Although such experience could lead to some great custom market content ideas like a custom stock ticker with related news included, you don't need to be at the level of head of IR content for an IR services firm to work with our feeds. And unlike investor relations data feeds that typically carry steep licensing feeds, our RediNews RSS feeds are provided to you free of charge. To give our feeds a try, look for the RSS icon for any news page (which will look like this): .

RDUS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.